New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine

This publication has 19 references indexed in Scilit:

• Treatment of Kala-Azar in Southern Sudan using a 17-Day Regimen of Sodium Stibogluconate Combined with Paromomycin: A Retrospective Comparison with 30-Day Sodium Stibogluconate Monotherapy
  The American Journal of Tropical Medicine and Hygiene, 2007
• Injectable Paromomycin for Visceral Leishmaniasis in India
  New England Journal of Medicine, 2007
• Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004
  The Lancet Infectious Diseases, 2005
• Advances in leishmaniasis
  Published by Elsevier ,2005
• Oral Miltefosine for Indian Visceral Leishmaniasis
  New England Journal of Medicine, 2002
• Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda
  The Lancet Infectious Diseases, 2002
• Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial Commentary: cost and resistance remain issues
  BMJ, 2001
• Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic
  Clinical Infectious Diseases, 2000
• Epidemic Visceral Leishmaniasis in Sudan: A Randomized Trial of Aminosidine plus Sodium Stibogluconate versus Sodium Stibogluconate Alone
  The Journal of Infectious Diseases, 1993
• Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1992